MDMA-Assisted Therapy
Bergman Leads 60 Members in Letter to Highlight New Groundbreaking Therapy, Stop Veteran Suicide
Making Sense with Sam Harris: The Future of Psychedelic Medicine 2
The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy | Chacruna
Experts Endorse MDMA-assisted Therapy for PTSD
MAPS Remains Hopeful, Awaits FDA Decision on MDMA-Assisted Therapy for PTSD
Dear Friends and Allies, On June 4, 2024, the U.S. Food and Drug Administration (FDA) convened a meeting of the Psychopharmacologic Drugs Advisory Committee to evaluate Lykos Therapeutics’ (Lykos) New …
The State Committee of the Netherlands on MDMA: Report presentation by Wim van den Brink
View the report here.
MDMA /// Beyond Ecstasy | Report from the Dutch State Commission
Lykos Therapeutics Announces Completion of European Phase 2 Study for MDMA-Assisted Therapy for PTSD
Why does MDMA work for PTSD? A new study yields clues about psychedelics and trauma therapy | Vox
MAPS Celebrates Submission of New Drug Application to FDA for MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: December 13, 2023 MAPS Public Benefit Corporation (MAPS PBC) formally submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) which included data from …
MAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: September 14, 2023 Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder, MAPP2, have been published in Nature Medicine. MAPP2 …